Related Experiment Videos
Response to interferon therapy in children with chronic hepatitis C
1Department of Pediatrics, National Defense Medical College, Saitama, Japan.
The Journal of Pediatrics
|October 1, 1995
Summary
Interferon therapy can effectively treat chronic hepatitis C in children, with over half achieving a complete response. Lower pretreatment hepatitis C virus RNA levels predict successful treatment outcomes.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Virology
Background:
- Chronic hepatitis C is a significant liver disease in children.
- Interferon-based therapies have been used to treat chronic hepatitis C.
- Predictors of treatment success in pediatric populations require further investigation.
Purpose of the Study:
- To assess the efficacy of interferon therapy in children with chronic hepatitis C.
- To identify factors influencing treatment outcomes in this cohort.
- To establish correlations between pretreatment viral load and treatment response.
Main Methods:
- A cohort of 18 children with chronic hepatitis C was treated with interferon.
- Treatment outcomes were evaluated, including rates of complete response.
- Pretreatment serum hepatitis C virus ribonucleic acid (RNA) titers were measured and analyzed.
Main Results:
- A complete response to interferon therapy was observed in 10 out of 18 children (56%).
- A significant correlation was found between lower pretreatment serum hepatitis C virus RNA levels (≤10^7 copies/ml) and achieving a complete response.
- Higher viral loads were associated with a lower likelihood of complete response.
Conclusions:
- Interferon therapy is a viable treatment option for chronic hepatitis C in children.
- Pretreatment hepatitis C virus RNA titer is a significant predictive factor for treatment success.
- Targeting therapy based on viral load may optimize outcomes in pediatric chronic hepatitis C management.